Thorough understanding of the efficacy and safety benchmarks set by competitors helps in appropriately gauging the opportunities or challenges while pursuing clinical development of an asset.

MedDx provides actionable insights to support clinical development of your asset by providing in-depth pipeline/clinical trial analysis, development and testing of an optimum target product profile (TPP) and target opportunity profile (TOP) throughout the patient journey.

This involves development of TPP/TOP through secondary sources and testing it with the KOLs/prescribers/payers/industry experts.